Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting

Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting

Abstract Objectives A growing body of evidence supports the effectiveness of injectable diacetylmorphine (i.e., heroin) for individuals with treatment-refractory opioid use disorder. Despite this evidence, and the increasing toll of opioid-associated morbidity and mortality, it remains controversial...

Full description

Bibliographic Details
Main Authors: Jan Klimas, Huiru Dong, Nadia Fairbairn, Eugenia Socías, Rolando Barrios, Evan Wood, Thomas Kerr, Julio Montaner, M.-J. Milloy
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Addiction Science & Clinical Practice
Subjects:
Substance-related disorders
Heroin
HIV/AIDS
Illicit drug use
Opioid agonist treatment
Online Access:http://link.springer.com/article/10.1186/s13722-017-0104-y

Internet

http://link.springer.com/article/10.1186/s13722-017-0104-y

Similar Items